Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Heart failure is a serious, chronic condition. While medication can help the heart recover and improve its function, this study suggests that the medications themselves may continue to protect the ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

Everyday activities that used to be easy may become challenging ... Not everyone with heart failure responds to drug treatments. In some cases, a doctor may recommend surgery to address the ...

Both diseases can be caused by changes (mutations) in the same gene that makes a protein called tropomyosin, which helps ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...